ALTYA
Live / Allowed — Second extension granted (statement of use) (as of 05 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Dec 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98908210
- Mark type
- Word mark
- Filed
- 17 Dec 2024
- Published for opposition
- 08 Jul 2025
- Attorney of record
- Lisa L. Mueller
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations to treat inflammatory diseases and disorders, and diseases and disorders of the immune system, dermatomyositis, systemic lupus erythematosus (SLE), hidradenitis suppurativa, scleroderma, sarcoidosis, juvenile dermatomyositis, non-infectious uveitis, and Crohn's Disease
Owner
- PRIOVANT THERAPEUTICS, INC., Durham, NC, US
- PRIOVANT THERAPEUTICS, INC., NEW YORK, NY, US
Prosecution history
- 06 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Aug 2026 — SOU EXTENSION 2 GRANTED
- 05 Aug 2026 — SOU EXTENSION 2 FILED
- 05 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 14 May 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 May 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 14 May 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 14 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Feb 2026 — SOU EXTENSION 1 GRANTED
- 06 Feb 2026 — SOU EXTENSION 1 FILED
- 06 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 02 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Jul 2025 — PUBLISHED FOR OPPOSITION
- 02 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED